Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "EIR"

3460 News Found

Experts call for precision diagnosis and standardised neonatal protocols
Hospitals | April 15, 2026

Experts call for precision diagnosis and standardised neonatal protocols

The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists


Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion
Healthcare | April 15, 2026

Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion

At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning


Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure
Hospitals | April 15, 2026

Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure

Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform


Vetter ramps up global clinical manufacturing push with major US & Europe expansion
News | April 15, 2026

Vetter ramps up global clinical manufacturing push with major US & Europe expansion

The goal is to better support drug developers as programs move from laboratory research into clinical trials


NantBioRenewables expands US manufacturing footprint in Alabama
Biotech | April 15, 2026

NantBioRenewables expands US manufacturing footprint in Alabama

To boost compostable packaging, resin innovation, and supply chain speed


Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations
R&D | April 15, 2026

Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations

The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations


FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application
Drug Approval | April 15, 2026

FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application

The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck


Bisleri expands CSR support for rural mental health programme in MP
Healthcare | April 15, 2026

Bisleri expands CSR support for rural mental health programme in MP

Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district


FDA presses 2,200+ companies to fix missing clinical trial results
News | April 15, 2026

FDA presses 2,200+ companies to fix missing clinical trial results

Move amid evidence of widespread reporting gaps